Michael Davis
  1. Partner

Mr. Davis is a partner in Davis Polk’s Corporate Department, practicing in the Mergers and Acquisitions Group. He advises U.S. and international corporate and private equity clients on a full range of transactions, both domestic and cross-border, including mergers, acquisitions, investments, joint ventures and collaborations, spinoffs and restructurings, special committee representations and defensive and corporate governance advice.

Work Highlights

U.S./International Mergers and Acquisitions Transactions

  • Mereo BioPharma Group on its combination with OncoMed Pharmaceuticals
  • Baker Hughes, a GE company on a series of long-term agreements that amend the commercial and technological relationships with General Electric Company
  • ORIX Corporation USA on its acquisition of NXT Capital
  • Charles River Laboratories on its acquisitions of MPI Research and WIL Research
  • ABB on its acquisition of GE Industrial Solutions
  • Baker Hughes on its combination with GE Oil & Gas
  • Mitsubishi Tanabe Pharma on its acquisition of NeuroDerm
  • Anacor Pharmaceuticals on its acquisition by Pfizer
  • Biotie Therapies on its sale to Acorda Therapeutics
  • Prosensa on its acquisition by BioMarin
  • Baker Hughes on its proposed merger with Halliburton
  • Daiichi Sankyo on the merger between Ranbaxy and Sun Pharmaceuticals
  • Maidenform on its acquisition by Hanesbrands
  • Warner Chilcott on its acquisition by Actavis
  • Heinz on its acquisition by Berkshire Hathaway and 3G Capital
  • Bertelsmann on various transactions including the formation of Penguin Random House
  • Penguin Random House on the sale of Author Solutions
  • RTL Group on various transactions
  • Dai-ichi Life on its strategic alliance with Janus
  • Thomas & Betts on its sale to ABB
  • Cigna on its acquisition of HealthSpring
  • Shionogi on its acquisition of Sciele Pharma
  • Private equity sponsor clients on various acquisitions, investments and divestitures


Mr. Davis is consistently recognized as a leader in the legal industry:

  • Chambers USA – Corporate/M&A, Leading Individual
  • IFLR1000 – “Rising Star” 
  • Legal 500 Latin America

Of Note

  • Member, Committee on Mergers, Acquisitions & Proxy Contests, New York City Bar
  • Speaks regularly as a panelist on a variety of topics, including most recently at:
    • Practising Law Institute’s 16th Annual Private Equity Forum
    • "The Future of Global-Style Governance and Shareholder Activism in Japan," co-hosted with Mergermarket
    • Japan Society’s seminar on "Activism, Independence, Stewardship – Current Trends in U.S. and Japanese Corporate Governance"
    • The Trout Group’s Private Company Showcase
    • 9th Annual Wall Street Unplugged seminar for life science companies

Professional History

  • Partner, 2007-present
  • London office, 2003-2004 
  • Associate, Davis Polk, 1999-2007 
  • Associate, Mallesons Stephen Jaques, 1998

Bar Admissions

  • State of New York


  • LL.B., University of Tokyo, Faculty of Law, 1996
  • LL.B., University of Sydney Law School, 1997
    • First Class Honours
    • University Medal
  • LL.M., Harvard Law School, 1999


  • Japanese